CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T‐cell lymphomas

J Yamamoto, K Ohuchi, R Amagai, Y Roh… - Skin Health and …, 2023 - Wiley Online Library
Bexarotene is often administered to phototherapy‐resistant early cutaneous T‐cell
lymphoma (CTCL) patients as one of the first‐line therapies in real‐world practice. Since …

Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA

J Kim, JV Pena, HP McQueen, L Kong, D Michael… - Cancer Gene …, 2024 - nature.com
Double-stranded DNA (dsDNA) in the cytoplasm of eukaryotic cells is abnormal and typically
indicates the presence of pathogens or mislocalized self-DNA. Multiple sensors detect …

Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory …

K Ishitsuka, T Yasukawa, Y Tsuji - Hematological Oncology, 2024 - Wiley Online Library
Mogamulizumab is a humanized antibody targeting CC chemokine receptor 4 (CCR4). This
post‐marketing surveillance was conducted in Japan as a regulatory requirement from 2014 …

[HTML][HTML] Chemokine-targeted nanoparticles: stimulation of the immune system in cancer immunotherapy

R Singh, P Srivastava, PP Manna - Exploration of Immunology, 2023 - explorationpub.com
Surgery, chemotherapy, radiation therapy, and immunotherapy are potential therapeutic
choices for many malignant and metastatic cancers. Despite adverse side effects and pain …

[HTML][HTML] Features of Peripheral Blood Th-Cell Subset Composition and Serum Cytokine Level in Patients with Activity-Driven Ankylosing Spondylitis

PA Shesternya, AA Savchenko, OD Gritsenko… - Pharmaceuticals, 2022 - mdpi.com
Th cells may exhibit pathological activity depending on the regulatory and functional signals
sensed under a wide range of immunopathological conditions, including ankylosing …

[HTML][HTML] Reduced CC Chemokine Receptor 4 Expression in Tumor Cells after Lenalidomide Treatment for Adult T-Cell Leukemia/Lymphoma: A Case Report

M Shimizu, T Yokote, J Hatooka, Y Kinoshita… - Case Reports in …, 2024 - karger.com
Introduction: CC chemokine receptor 4 (CCR4), which is involved in leukocyte migration, is
expressed in most tumor cells in patients with adult T-cell leukemia/lymphoma (ATLL). Case …

Adult T-cell Leukemia/Lymphoma (ATL) in the Nasal and Paranasal Cavity: Four Cases Report

H Nagano, H Matsumoto, Y Miyamoto, K Takumi… - Indian Journal of …, 2024 - Springer
Adult T-cell leukemia/lymphoma (ATL) is a form of leukemia caused by the human T-cell
leukemia virus type I (HTLV-1). Otolaryngologists often diagnose ATL based on cervical …

Systematic pan-cancer analysis reveals XCR1 as a Prognostic and Immunological Biomarker

L Cui, J Chen, C Li, Y Yu, S Xu - 2023 - researchsquare.com
Background Chemokines and their receptors play an important role in immune monitoring
and immune defense during the tumor growth and metastasis. However, their prognostic …

Interferon regulatory factor 3 upregulates the Treg recruitment factor CCL22 in response to double-stranded DNA in cancer cells

JG Kim, JV Peña, HP McQueen, L Kong, D Michael… - bioRxiv, 2022 - biorxiv.org
Cancer immunotherapy holds great promise for the treatment of solid tumors, but its
effectiveness is hindered by the recruitment of regulatory T cells (Tregs), which inhibit anti …

Characterization of peripheral immune events in primary colorectal cancer patients

C Lu - 2022 - edoc.ub.uni-muenchen.de
1.1 Colorectal Cancer 1.1. 1 The Nature of Colorectal Cancer Colorectal cancer (CRC) is the
third most frequent carcinoma and the second leading cause of cancer-associated death …